Virology News and Research

Latest Virology News and Research

West Nile virus found in Champaign County

Dr. Eric E. Whitaker, state public health director, today reported that a dead crow collected in Rantoul in Champaign County has tested positive for West Nile virus.

21 May 2004

WHO reports likely Ebola case in Sudan

As of 10 May, WHO reported cases of Ebola haemorrhagic fever syndrome in Hai-Cuba, Yambio, Western Equatoria Region, south Sudan. A rapid assessment team is in the field to investigate the situation. Clinical samples have been collected and preliminary results are expected soon.

21 May 2004

Pacemaker-type device and medicines reduce hospital stays and death rates

A nationwide clinical trial of more than 1,600 heart failure patients showed that when medicines are combined with the use of a pacemaker-type device that resynchronizes both sides of the heart, hospital stays and death rates drop significantly.

20 May 2004

FDA finalizes new rule on donor eligibility for human tissues and cells

FDA today published a final rule establishing donor eligibility criteria for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps) to help prevent the transmission of communicable disease when these products are transplanted.

20 May 2004

Watching for West Nile virus, dead bird and mosquito monitoring resumes

Warmer spring weather and the coming mosquito season has the Department of Health on the lookout for West Nile virus again, working with local health departments to identify mosquitoes, track dead birds and monitor any human illness across Washington. This season brings mosquito-breeding weather and the threat of mosquito-borne disease, including West Nile virus.

20 May 2004

Causes of hepatitis and potential therapies that may improve care presented in study

Hepatitis, a potentially serious disease caused by a virus that attacks the liver, is a major problem worldwide. Hepatitis A is generally food-borne, while hepatitis B and C spread primarily through parenteral or sexual routes. Hepatitis B and C can be life-long, potentially deadly chronic infections.

19 May 2004

Network formed to tackle potentially fatal reaction to smallpox vaccine

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), launched the Atopic Dermatitis and Vaccinia Network (ADVN), a nationwide research group that seeks to reduce the risk of eczema vaccinatum (EV), a severe and potentially deadly complication of smallpox immunization.

19 May 2004

$20.7 million to make smallpox vaccine safer

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a five-year, $20.7 million grant to National Jewish Medical and Research Center to lead a consortium of academic medical centers trying to make smallpox vaccines safer for millions of people with atopic dermatitis, also known as eczema.

19 May 2004

WHO experts and the Chinese authorities are still trying to determine the exact cause of the recent SARS outbreak

The investigation has centred primarily on the National Institute of Virology in Beijing where experiments using live and inactivated SARS coronavirus have been carried out. Two researchers at the Institute developed SARS in late March and mid-April. The outbreak was reported on April 22 and the Institute was closed a day later.

19 May 2004

Multimillion-dollar electron microscope unveils shapes of viruses and proteins

With a multimillion-dollar electron microscope and computer programs that can pick out the shapes of structures only six atoms wide, Dr. Wah Chiu and his colleagues at Baylor College of Medicine in Houston are attempting to explain the intricate structures of viruses and proteins.

19 May 2004

Latest SARS outbreak contained, but biosafety concerns remain

It has been more than three weeks since the last case was placed in isolation in China's latest SARS outbreak, prompting the World Health Organization to declare that the chain of human-to- human transmission appears to have been broken.

18 May 2004

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Benitec Ltd. today announced the acquisition of Avocel, Inc. of Sunnyvale, CA, a leading RNAi therapeutics company, and the establishment of its wholly-owned US subsidiary, Benitec, Inc. Through the acquisition, Benitec gains its first in-house advanced therapeutic development program using DNA-directed RNAi (ddRNAi) to target the Hepatitis C virus.

18 May 2004

Manipulation of the body’s own natural killer cells to destroy cells containing the HIV virus

Current treatments for HIV block the virus from replicating, but don’t kill the cells that contain HIV. The existence of these HIV-harboring cells -- often called the “latent” or “resting reservoir” -- is regarded by many to be the main obstacle to finding a cure for HIV.

18 May 2004

Research suggests that weanling pigs are susceptible to West Nile virus infection

Since the emergence of West Nile virus in the Western Hemisphere in 1999, health care personnel have been on the lookout for signs of infection in people and animals. Recent research suggests that food processing personnel should beware of the presence of the virus in swine and a potential health risk to employees in pork processing plants.

17 May 2004

HHS to ensure safe, effective drugs delivered to developing countries under the President's $15 billion plan for AIDS relief

HHS Secretary Tommy G. Thompson today announced an expedited review process to ensure that the United States is providing safe, effective drugs to developing countries under the President's $15 billion Emergency Plan for AIDS Relief.

16 May 2004

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans to ensure that the thousands of HIV-infected people currently not receiving care through existing programs gain access to the services they need, says a new report from the Institute of Medicine of the National Academies.

16 May 2004

Genetically engineered viruses may create new class of cancer therapies

A genetically engineered virus can selectively kill cancerous cells in the lung and colon while leaving healthy cells intact, according to new research published today in Cancer Research by William Wold and colleagues at Saint Louis University School of Medicine.

15 May 2004

West Nile virus found in Arizona

Mosquito samples collected by Maricopa County health officials in the East Valley have tested positive for the West Nile virus, marking the arrival of the virus in the state in 2004.

15 May 2004

3 people with drug-resistant HIV become first to undergo a new form of gene therapy

The idea is to use a modified form of HIV to deliver an "antisense" gene to the immune cells that HIV infects. This is integrated into the cells' genome, and stays there until a cell is infected. Then it is switched on, and produces RNA complementary to the "sense" RNA encoding a viral protein. In theory, the RNAs should bind together, blocking viral replication.

14 May 2004

Largest study comparing leading hepatitis C treatments

Medical centers, hospitals, clinics and other treatment sites across the country are actively enrolling Americans with the hepatitis C virus (HCV) in a nationwide study that will for the first time determine which of the two FDA-approved pegylated interferon therapy regimens offers patients the best chance to eliminate the virus.

14 May 2004

Virology News and Research

Latest Virology News and Research

West Nile virus found in Champaign County

WHO reports likely Ebola case in Sudan

Pacemaker-type device and medicines reduce hospital stays and death rates

FDA finalizes new rule on donor eligibility for human tissues and cells

Watching for West Nile virus, dead bird and mosquito monitoring resumes

Causes of hepatitis and potential therapies that may improve care presented in study

Network formed to tackle potentially fatal reaction to smallpox vaccine

$20.7 million to make smallpox vaccine safer

WHO experts and the Chinese authorities are still trying to determine the exact cause of the recent SARS outbreak

Multimillion-dollar electron microscope unveils shapes of viruses and proteins

Latest SARS outbreak contained, but biosafety concerns remain

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Manipulation of the body’s own natural killer cells to destroy cells containing the HIV virus

Research suggests that weanling pigs are susceptible to West Nile virus infection

HHS to ensure safe, effective drugs delivered to developing countries under the President's $15 billion plan for AIDS relief

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans

Genetically engineered viruses may create new class of cancer therapies

West Nile virus found in Arizona

3 people with drug-resistant HIV become first to undergo a new form of gene therapy

Largest study comparing leading hepatitis C treatments

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production